Glimisave MV 3.3 F Tablet 15's
Rs. 208.83
Title
Glimisave MV 3.3 F Tablet 15's
Prescription drug
About: Glimisave MV 3.3 F is a triple antidiabetic tablet for adults with type 2 diabetes inadequately controlled on dual therapy.
Usage Instructions: Usually taken once daily with a main meal; dose is individualized by the physician.
Benefits: Provides strong control of fasting and post‑meal blood glucose and helps lower HbA1c.
How it Works: Combines glimepiride (sulfonylurea), metformin (biguanide) and voglibose (alpha‑glucosidase inhibitor) to increase insulin secretion, improve insulin sensitivity, reduce hepatic glucose output, and delay intestinal carbohydrate absorption.
Side Effects: Hypoglycemia, GI upset, flatulence, abdominal discomfort may occur.
Safety Advice: Regular blood‑glucose and renal monitoring are recommended; follow structured meals to avoid lows.
Storage: Store below 25–30°C in a dry place away from light.
Usage Instructions: Usually taken once daily with a main meal; dose is individualized by the physician.
Benefits: Provides strong control of fasting and post‑meal blood glucose and helps lower HbA1c.
How it Works: Combines glimepiride (sulfonylurea), metformin (biguanide) and voglibose (alpha‑glucosidase inhibitor) to increase insulin secretion, improve insulin sensitivity, reduce hepatic glucose output, and delay intestinal carbohydrate absorption.
Side Effects: Hypoglycemia, GI upset, flatulence, abdominal discomfort may occur.
Safety Advice: Regular blood‑glucose and renal monitoring are recommended; follow structured meals to avoid lows.
Storage: Store below 25–30°C in a dry place away from light.
₹208.83
MRP: ₹232.03
Save ₹23.20
(9%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Glimisave MV 3.3 F is a triple antidiabetic tablet for adults with type 2 diabetes inadequately controlled on dual therapy.
Usage Instructions: Usually taken once daily with a main meal; dose is individualized by the physician.
Benefits: Provides strong control of fasting and post‑meal blood glucose and helps lower HbA1c.
How it Works: Combines glimepiride (sulfonylurea), metformin (biguanide) and voglibose (alpha‑glucosidase inhibitor) to increase insulin secretion, improve insulin sensitivity, reduce hepatic glucose output, and delay intestinal carbohydrate absorption.
Side Effects: Hypoglycemia, GI upset, flatulence, abdominal discomfort may occur.
Safety Advice: Regular blood‑glucose and renal monitoring are recommended; follow structured meals to avoid lows.
Storage: Store below 25–30°C in a dry place away from light.
Usage Instructions: Usually taken once daily with a main meal; dose is individualized by the physician.
Benefits: Provides strong control of fasting and post‑meal blood glucose and helps lower HbA1c.
How it Works: Combines glimepiride (sulfonylurea), metformin (biguanide) and voglibose (alpha‑glucosidase inhibitor) to increase insulin secretion, improve insulin sensitivity, reduce hepatic glucose output, and delay intestinal carbohydrate absorption.
Side Effects: Hypoglycemia, GI upset, flatulence, abdominal discomfort may occur.
Safety Advice: Regular blood‑glucose and renal monitoring are recommended; follow structured meals to avoid lows.
Storage: Store below 25–30°C in a dry place away from light.